![Matthew Outten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Outten
Corporate Officer/Principal en
BRIDGEBIO PHARMA, INC.
.
Perfil
Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.
Cargos activos de Matthew Outten
| Empresas | Cargo | Inicio |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/02/2019 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Matthew Outten.
| Empresas | Cargo | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Formación de Matthew Outten.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
27
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Outten
